글로벌 항감염제 시장 – 2030년까지의 산업 동향 및 예측

항감염제 시장 분석 및 규모

항감염제는 수십 년 동안 여러 제약 회사의 주요 세그먼트였습니다. 지난 20년 동안 감염률은 상당히 증가했으며, 주로 저소득 및 중소득 국가에서 증가했습니다. 고정 복용량 조합과 질병 특정 치료에 대한 수요 증가와 같은 제형의 여러 발전은 항바이러스제 수요 의 주요 요인 중 일부입니다 . 표적 질병의 증가와 항감염제에 대한 인식 이니셔티브로 인해 항감염제 시장은 엄청나게 성장할 것으로 예상됩니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 항감염제 시장의 성장률을 분석합니다. 항감염제 시장의 예상 CAGR은 언급된 예측 기간 동안 약 4%인 경향이 있습니다. 시장은 2022년에 1,350억 달러로 평가되었으며 2030년까지 1,847억 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

항감염제 시장 범위 및 세분화

시장 정의

항감염제는 근육 경련을 억제하는 치료제의 한 종류입니다. 이러한 유형의 약물은 특히 위장관에서 평활근 이완을 자극하는 데 도움이 됩니다. 항경련제는 일반적으로 복통과 경련과 같은 증상을 치료합니다. 이들은 과민성 대장 증후군 증상의 치료에 가장 일반적으로 사용됩니다.  

글로벌 항감염제 시장 역학

운전자

• 감염병에 대한 인식 증가

세계 여러 지역에서 다중 약물 내성 유기체의 수가 크게 증가했으며, 이는 항감염제 혁신의 중요성을 더욱 부추깁니다. 수많은 연구소가 대중 사이에서 감염병 에 대한 인식을 높이기 위한 특정 이니셔티브나 캠페인을 수립했습니다 . 예를 들어, 세계보건기구는 2021년 11월에 '인식 확산, 내성 중단'이라는 주제로 세계 항균제 인식 주간(WAAW)을 개최하여 항균제 내성에 대한 인식을 높였습니다. 따라서 이러한 인식 이니셔티브는 시장 성장을 촉진합니다.

• 경구 약물에 대한 수요 증가

경구 약물은 시장 성장을 증가시킬 것으로 추정됩니다. 이 세그먼트는 많은 제품이 캡슐 형태와 정제 형태로 제공되며 매우 일반적이고 편리한 투여 경로이기 때문에 글로벌 시장을 확대할 것으로 예상됩니다.

기회

• 항감염제 출시

Major market players are releasing many products that are helping in boosting the growth of the market.  For instance, in February 2021, Pfizer announced the launch of the C. difficile Awareness Initiative. C. difficile is an infectious bacterium that can cause a serious and potentially life-threatening infection related with symptoms from diarrhea to severe intestinal inflammation. The article specified that an estimate of about 462,000 C. difficile infection cases were being registered in the U.S. each year. The growing number of initiatives by several organizations and major market players on spreading awareness regarding infectious diseases are projected to boost the market growth. Furthermore, Xellia Pharmaceuticals, which is a pharmaceutical manufacturer specializing in anti-infective treatments, in August 2021, opened its manufacturing site in Cleveland, Ohio in U.S. The company released the first anti-infectives which is manufactured at the site for distribution to U.S. hospitals. Such activities are projected to increase the market growth during the forecast period.

Restraints/Challenges

• Lack of skilled professionals

The huge lack of qualified personnel who are not aware of the drugs options to give patients to could hamper the growth of the global anti-infective drugs market during the forecast period 2023-2030.

• Side-effects of anti-infective drugs

Several side effects such as weakness, dizziness, blurred vision, rashes, nausea, dry mouth, and abdominal bloating hamper the market growth. Any of the drug use is restricted because of the government developed guidelines to monitor how and where the medications are utilized.

This anti-infective drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anti-infective drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Anti-Infective Drugs Market Scope

The anti-infective drugs market is segmented on the basis of product type, indication,  route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Antibiotics
• Antivirals
• Antifungals
• Others

Indication

• HIV Infections
• Pneumonia
• Hepatitis
• Herpes Simplex Virus
• Influenza
• Others

Route of Administration

• Oral
• Topical
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Anti-Infective Drugs Market Regional Analysis/Insights

The anti-infective drugs market is analyzed and market size insights and trends are provided by product type, indication,  route of administration, distribution channel and end-user as referenced above.

The major countries covered in the anti-infective drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for anti-infective drugs market throughout the forecasted period because of the sophisticated healthcare infrastructure, increasing awareness in society, well-established distribution channels, and a huge presence of e-commerce across the U.S. and Canada.

Asia-Pacific dominates the market because of the increasing attention of major market players to establish numerous emerging economics with significant growth. With the opening of several new hospitals and pharmacies in this area, the market is expanding.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Anti-Infective Drugs Market Share Analysis

The anti-infective drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anti-infective drugs market

Key players operating in the anti-infective drugs market include:

• Takeda Pharmaceutical Company Limited (Japan)
• Johnsons & Johnsons Services Inc (U.S.)
• Boehringer Ingelheim International GmbH (Germany)
• Abbvie, Inc (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Sanofi (France)
• GSK Plc. (U.K.)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Alvogen (U.S)
• 히크마 제약(영국)
• Alembic Pharmaceuticals Limited(인도)
• Zydus 그룹(인도)

SKU-52944